Nasdaq Nordic weekly wrap: Novo Nordisk shock drags Denmark as OMXN40 ends down
Denmark’s OMXC25 index dropped 4.7% last week, hit by Novo Nordisk’s 16% slide after an obesity-drug trial setback. The OMX Nordic 40 lost 2.2% for the week, while Sweden’s OMXS30 rose 1.3%. Traders now await U.S. jobs data on March 6 and central bank meetings later in March.